Lo que hay que saber sobre la ibogaínanews2024-03-09T10:02:51+00:00March 9th, 2024|The New York Times|
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapynews2024-03-05T18:32:51+00:00March 5th, 2024|The New York Times|
What to Know About Ibogaine, a Psychedelicnews2024-03-05T08:00:07+00:00March 5th, 2024|The New York Times|
We Need to Rethink Our Treatment of Painnews2023-12-24T14:00:21+00:00December 24th, 2023|The New York Times|
Telehealth Prescription Rules May Change Soon. Here’s What to Know.news2023-04-05T09:00:19+00:00April 5th, 2023|The New York Times|
The Adderall Shortage Reflects Bad Drug Policynews2023-03-25T13:00:09+00:00March 25th, 2023|The New York Times|
More Doctors Can Now Prescribe Buprenorphine to Opioid Users. Will It Help?news2023-03-03T08:00:11+00:00March 3rd, 2023|The New York Times|
Biden Proposal Would Ban Online Prescribing of Certain Drugsnews2023-02-25T10:49:56+00:00February 25th, 2023|The New York Times|
McKinsey Guided Companies at the Center of the Opioid Crisisnews2022-06-29T23:24:22+00:00June 29th, 2022|The New York Times|